Pennant Group, Inc.

Combined revenue from reimbursement under the Medicare and Medicaid programs accounted for 64.3% and 64.0% of the Company’s revenue for the three and six months ended June 30, 2026, and 61.3% of the Company’s revenue for both the three and six months ended June 30, 2025.

Combined revenue from reimbursement under the Medicare and Medicaid programs accounted for 63.9% of the Company’s revenue the three months ended March 31, 2026, and 61.2% of the Company’s revenue for the three months ended March 31, 2025.

Revenue from reimbursement under the Medicare and Medicaid programs accounted for 61.5%, 61.5%, and 62.6% of the Company's revenue for the years ended December 31, 2025, 2024, and 2023, respectively.

Combined revenue from reimbursement under the Medicare and Medicaid programs accounted for 61.2% and 61.3% of the Company’s revenue the three and nine months ended September 30, 2025, and 60.7% and 61.6% of the Company’s revenue for the three and nine months ended September 30, 2024, respectively.

Medicare $ 62,264 $ 89,387 $ — $ 151,651 50.9 %

Medicare $ 60,550 $ 84,308 $ — $ 144,858 50.8 %

Because of this diversified portfolio, our blended payor mix was 48.4% Medicare, 13.1% Medicaid, 15.0% managed care and 23.5% private pay and other payment sources for the year ended December 31, 2025.

Medicare $ 41,830 $ 67,001 $ — $ 108,831 47.5 %

Medicare $ 39,625 $ 64,196 $ — $ 103,821 47.3 %

Medicare $ 39,676 $ 61,449 $ — $ 101,125 48.2 %

Medicare $ 127,891 $ 207,971 $ — $ 335,862 48.3 %

Medicare $ 32,403 $ 54,516 $ — $ 86,919 48.1 %

The Company records revenue from Medicare, Medicaid, and managed care programs as services are performed at their expected net realizable amounts under these programs.

The Company records revenue from Medicare, Medicaid, and managed care programs as services are performed at their expected net realizable amounts under these programs.

Because of this diversified portfolio, our blended payor mix was 48.4% Medicare, 13.1% Medicaid, 15.0% managed care and 23.5% private pay and other payment sources for the year ended December 31, 2025.

The Company records revenue from Medicare, Medicaid, and managed care programs as services are performed at their expected net realizable amounts under these programs.

We derive revenue from a diversified blend of payors including Medicare and Medicaid programs, private pay patients and residents, and managed care payors.